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1 Letter to the Editor
2 Patterns in the epidemiology of candidemia as aQ1
3 consequence of antibiotic and antifungal exposure
Q54 Despite huge efforts in infection prevention and control in
5 burns units, candidemia and invasive candidiasis remains a
6 problematic complication that contributes to an added
7 morbidity and possibly mortality [15]. Burn patients have
8 the ultimate risk profile for being infected with opportunisticQ3
9 pathogens such as Candida [6]. Burn patients experience
10 extensive wounds requiring multiple surgical procedures with
11 substantial blood loss, extended length of hospitalization,
12 prolonged intravascular and bladder catheterization, a cata-
13 bolic metabolism, and a down-regulated immune function dueQ2
14 to excessive and sustained inflammation and blood loss.
15 We read with interest the article by Zhou et al. concerning
16 risk factors for candidemia in major burn patients [7]. They
17 report on a cohort of 410 burn victims of which 39 developed
18 candidemia. Of note, a worrying trend in occurrence rate was
19 observed over the 6-year study period (from approximately 6%
20 to 17.5%). The authors identified classic risk factors for
21 candidemia such as renal replacement therapy and prior
22 colonization [8]. Broad-spectrum antibiotic therapy, another
23 classic risk factor, was not recognized as associated with
24 candidemia. This however, can be explained by the high use of
25 these agents in the study cohort. Overall, 96% of patients were
26 exposed to broad-spectrum antibiotic agents, thereby leaving
27 no discriminative power to link broad-spectrum antibiotics
28 with an increased risk of candidemia. The high rate of
29 antibiotic use might also be the very reason for the high rate
30 of candidemia [9]. In that regard, we wonder if the authors can
31 provide more information on their antibiotic policy in the burn
32 ICU. For example, do they routinely prescribe antibiotic
33 therapy in all patients burned >20% total burned surface area?
34 At the same line, the authors report a high rate of antifungal
35 prophylaxis (44%) [7]. We assume this might be the reason for
36 the high proportion of non-albicans Candida species (73%) as
37 well as the high rate of reduced susceptibility to fluconazole
38 (36%) as this has been described previously on individual
39 patient level and unit level [1012]. Therefore, antifungal
40 prescription should be considered an essential part of
41 antimicrobial stewardship.
42 In this regard we would invite the authors to provide
43 detailed information about their antibiotic/antifungal policy,
44 either in prophylaxis or therapy in order to allow correct
45 interpretation of the data reported. In addition, we wonder if
46they can link the increasing trend in candidemia with any Q7
47increase in the use of antimicrobials in recent years.
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